Professor Alon Harris is an internationally recognized scientist focusing on glaucoma risk factor assessment, monitoring techniques for structural and functional glaucoma progression, ocular perfusion assessment, glaucoma medications, generic medications, imaging methodologies and population based studies. He is also a consultant to many biotech and pharmaceutical companies. His center is one of the world-leading centers for the study of ocular blood flow. Professor Harris has published over 300 peer-reviewed journal articles, 18 books and more than 40 book chapters. Professor Harris has received numerous national and international awards including the Sam Rothberg Glaucoma Award; the William and Mary Greve International Research Scholar Award from the Research to Prevent Blindness organization; the Glenn W. Irwin Jr., MD., Experience Excellence Recognition Award; Edmund Benjamin Spaeth Oration Award for Outstanding Clinical Research; American Academy of Ophthalmology Achievement Award and Letzter Endowed Chair of Ophthalmology Professor Harris has received over 5 million dollars in research funds from prestigious institutions including the National Institutes of Health, National Science Foundation, American Diabetes Association, and the National Eye Institute in the United States. Professor Harris holds two patents in the United States: 1) Novel Treatment of Macular Edema; and 2) Method to Increase Retinal and Optic Nerve Head Blood Flow.
Research Interest: Physiology and Biophysics